Anti-Cancer Drug Made More Specific By Modification

Imatinib (marketed as Gleevec in the US and Glivec in Europe and Australia) is used to treat various cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It can be used to treat these two distinct types of cancer because they are caused by related proteins - tyrosine kinases. [click link for full article]

More: continued here

Filed under: Biology on December 6th, 2007